Crohn's Disease Clinical Trials

Find Crohn's Disease Clinical Trials Near You

Virtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Crohn's disease is a chronic, incurable inflammatory bowel disease with an unpredictable course, characterized by alternating remission and inflammatory flares. Current follow-up strategies are poorly suited to early flare detection, leading to uncontrolled disease progression and complications. A major clinical challenge is distinguishing reversible inflammatory activity from irreversible intestinal fibrosis, as existing imaging techniques lack specificity. This study aims to perform comprehensive ex vivo multiparametric MRI, combined with biophysical measurements and histopathology, on resected intestinal specimens to precisely map inflammation and fibrosis and to validate in vivo MRI-derived biomarkers for personalized therapeutic decision-making.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years.

• Diagnosis of Crohn's disease and undergoing intestinal resection surgery at CHRU Nancy.

• Patient has not objected to the reuse of personal data and biological samples for the purposes of this research.

Locations
Other Locations
France
CHRU Nancy
RECRUITING
Vandœuvre-lès-nancy
Contact Information
Primary
Guillaume DROUOT, PhD
g.drouot@chru-nancy.fr
+33383157666
Time Frame
Start Date: 2026-09-25
Estimated Completion Date: 2028-10-01
Participants
Target number of participants: 60
Treatments
Crohn's Disease Patients Undergoing Intestinal Resection
Patients with Crohn's disease undergoing planned intestinal resection surgery. Resected intestinal specimens will be analyzed ex vivo using multiparametric magnetic resonance imaging, biophysical measurements (mechanical and electrical properties), and histopathological examination. No experimental intervention is performed on participants beyond standard surgical care.
Related Therapeutic Areas
Sponsors
Leads: Central Hospital, Nancy, France

This content was sourced from clinicaltrials.gov